Prime Medicine Inc (PRME)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Prime Medicine Inc-Aktie (PRME)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	23.31% 1.115	1.454	2.183	0.209	-
Operating Expenses	1.20% 54.49	53.85	46.41	54.44	55.67
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	1.20% 54.49	53.85	46.41	54.44	55.67
Operating Income/Loss	1.88% -53.38	-52.39	-44.22	-54.23	-55.67
Nonoperating Income/Loss	56.57% 0.786	0.502	1.946	1.714	0.211
Income/Loss From Continuing Operations Before Tax	102.15% 1.115	-51.89	2.183	0.209	-55.33
Income Tax Expense/Benefit, Deferred	-	-	-	-	-0.134
Income Tax Expense/Benefit	-	-	-	-	-0.134
Income/Loss From Continuing Operations After Tax	1.35% -52.59	-51.89	-42.28	-52.52	-55.33
Net Income/Loss	1.35% -52.59	-51.89	-42.28	-52.52	-55.33
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.30% 129.19	130.88	4.108	119.76	119.19
Diluted Average Shares	1.30% 129.19	130.88	4.108	119.76	119.19
Basic Earnings Per Share	2.50% -0.41	-0.40	-0.31	-0.44	-0.46
Diluted Earnings Per Share	2.50% -0.41	-0.40	-0.31	-0.44	-0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%